N Engl J Med 2021;385: 896-907
Quick intake, provider review, and your protocol ships to your door from a licensed U.S
Then in an announcement on Tuesday, the drugmaker unveiled that the National Medical Products Administration (NMPA), Chinas top drug regulator, had allowed the injection to be used in weight reduction, making it the first GLP-1 receptor agonist officially available in the country for people who wish to lose weight but for diabetes-unrelated reasons
& Heber, D
Recommended starting dose: Discontinue other basal insulin and/or GLP-1 agonist before initiating Soliqua Patients naive to basal insulin or a GLP-1 agonist, currently on a GLP-1 agonist or less than 30 units of basal insulin daily: starting dose is 15 units once daily Patients currently on 30 to 60 units of basal insulin daily, with or without a GLP-1 agonist: starting dose is 30 units once daily Maintenance: titrate dose up or down by 2 - 4 units every week based on blood sugar goals Missed doses: resume dosing at the next scheduled dose
ReadyRx supports informed decision-making through transparent communication, accessible healthcare provider consultation, flexible program options that accommodate various budgets and commitments, and comprehensive patient education that enables realistic expectations and optimal protocol adherence